Delivery of tobramycin coupled to iron oxide nanoparticles across the biofilm of mucoidal Pseudonomas aeruginosa and investigation of its efficacy

Leisha M. Armijo; Michael Kopciuch; Zuzia Olszόwka; Stephen J. Wawrzyniec; Antonio C. Rivera; John B. Plumley; Nathaniel C. Cook; Yekaterina I. Brandt; Dale L. Huber; Gennady A. Smolyakov; Natalie L. Adolphi; Hugh D. C. Smyth; Marek Osiński

doi:10.1117/12.2043340

8 April 2014 Delivery of tobramycin coupled to iron oxide nanoparticles across the biofilm of mucoidal Pseudonomas aeruginosa and investigation of its efficacy

Leisha M. Armijo, Michael Kopciuch, Zuzia Olszόwka, Stephen J. Wawrzyniec, Antonio C. Rivera, John B. Plumley, Nathaniel C. Cook, Yekaterina I. Brandt, Dale L. Huber, Gennady A. Smolyakov, Natalie L. Adolphi, Hugh D. C. Smyth, Marek Osiński

Author Affiliations +

Proceedings Volume 8955, Colloidal Nanoparticles for Biomedical Applications IX; 89550I (2014) https://doi.org/10.1117/12.2043340
Event: SPIE BiOS, 2014, San Francisco, California, United States

Abstract

Pseudomonas aeruginosa bacterium is a deadly pathogen, leading to respiratory failure in cystic fibrosis and nosocomial pneumonia, and responsible for high mortality rates in these diseases. P. aeruginosa has inherent as well as acquired resistance to many drug classes. In this paper, we investigate the effectiveness of two classes; aminoglycoside (tobramycin) and fluoroquinolone (ciprofloxacin) administered alone, as well as conjugated to iron oxide (magnetite) nanoparticles. P. aeruginosa possesses the ability to quickly alter its genetics to impart resistance to the presence of new, unrecognized treatments. As a response to this impending public health threat, we have synthesized and characterized magnetite nanoparticles capped with biodegradable short-chain carboxylic acid derivatives conjugated to common antibiotic drugs. The functionalized nanoparticles may carry the drug past the mucus and biofilm layers to target the bacterial colonies via magnetic gradient-guided transport. Additionally, the magnetic ferrofluid may be used under application of an oscillating magnetic field to raise the local temperature, causing biofilm disruption, slowed growth, and mechanical disruption. These abilities of the ferrofluid would also treat multi-drug resistant strains, which appear to be increasing in many nosocomial as well as acquired opportunistic infections. In this in vitro model, we show that the iron oxide alone can also inhibit bacterial growth and biofilm formation.

Citation Download Citation

Leisha M. Armijo, Michael Kopciuch, Zuzia Olszόwka, Stephen J. Wawrzyniec, Antonio C. Rivera, John B. Plumley, Nathaniel C. Cook, Yekaterina I. Brandt, Dale L. Huber, Gennady A. Smolyakov, Natalie L. Adolphi, Hugh D. C. Smyth, and Marek Osiński "Delivery of tobramycin coupled to iron oxide nanoparticles across the biofilm of mucoidal Pseudonomas aeruginosa and investigation of its efficacy", Proc. SPIE 8955, Colloidal Nanoparticles for Biomedical Applications IX, 89550I (8 April 2014); https://doi.org/10.1117/12.2043340

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available